PTPN11 and diabetes mellitus: Importantly, the SHP-2 activity of monocytes from DM-patients (n = 8) was found to be elevated (30 ± 4.8%), confirming that upregulation of SHP-2 activity is a predominant feature in DM-patient-derived monocytes (Fig. 5c).